Evaluation of the sensitivity of red blood cell markers to detect photodynamic membrane damage

Transfusion

Volumn 44, Issue 5, 2004, Pages 716-721

  Wagner, Stephen J ^a   Skripchenko, Andrey ^a   Thompson Montgomery, Dedeene ^a   Awatefe, Helen ^a  

^a AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE MARKER; DIMETHYLMETHYLENE BLUE; DYE; LIPOCORTIN 5; METHYLENE BLUE; POTASSIUM ION; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLOOD BANK; BLOOD STORAGE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ERYTHROCYTE FRAGILITY; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMAN; HUMAN CELL; ION TRANSPORT; LIGHT EMITTING DIODE; MEMBRANE DAMAGE; PHOTODYNAMICS; POTASSIUM TRANSPORT; RED LIGHT; SENSITIVITY AND SPECIFICITY;

ANNEXIN A5; BIOLOGICAL MARKERS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HEMOLYSIS; HUMANS; PHOTOCHEMOTHERAPY; POTASSIUM; SENSITIVITY AND SPECIFICITY;

EID: 2342665607     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03356.x     Document Type: Article

References (27)

1. O'Brien JM, Montgomery RR, Burns WH, Gaffney DK, Sieber F. Evaluation of merocyanine 540-sensitized photoirradiation as a means to inactivate enveloped viruses in blood products. J Lab Clin Med 1990;116:439-47.
2. Neyndorff HC, Bartel DL, Tufaro F, Levy JG. Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood. Transfusion 1990;30:485-90.
3. Horowitz B, Rywkin S, Margolis-Nunno H, et al. Inactivation of viruses in red cell and platelet concentrates with aluminum phthalocyanine (AlPc) sulfonates. Blood Cells 1992;18:141-9.
4. Wagner SJ, Storry JR, Mallory DA, et al. Red cell membrane alterations associated with virucidal methylene blue phototreatment. Transfusion 1993;33:30-6.
5. Ben-Hur E, Rywkin S, Rosenthal I, Geacintov NE, Horowitz B. Virus inactivation in red cell concentrates by photosensitization with phthalocyanines: protection of red cells but not vesicular stomatitis virus with a water-soluble analogue of vitamin E. Transfusion 1995;35:401-6.
6. Moor AC, van der Veen A, Wagenaars-van Gompel AE, et al. Shelf-life of photodynamically sterilized red cell concentrates with various numbers of white cells. Transfusion 1997;37:592-600.
7. Prince AM, Pascual D, Meruelo D, et al. Strategies for evaluation of enveloped virus inactivation in red cell concentrates using hypericin. Photochem Photobiol 2000;71:188-95.
8. Mohr H. Methylene blue and thionine in pathogen inactivation of plasma and platelet concentrates. Transfus Apheresis Sci 2001;25:183-4.
9. Wagner SJ, Skripchenko A, Thompson-Montgomery D. Quinacrine enhances vesicular stomatitis virus inactivation and diminishes hemolysis of dimethylmethylene blue-phototreated red cells. Photochem Photobiol 2002;76:514-7.
10. Workshop: safety and efficacy of methods for reducing pathogens in cellular blood products used in transfusion (Internet). Rockville (MD): Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2002. Available from: http://www.fda.gov/cber/minutes/pathtrans/080702.pdf
11. Deziel MR, Girotti A. Lysis of resealed erythrocyte ghosts by photoactivated tetrapyrroles: estimation of photolesion dimensions. Int J Biochem 1980;14:263-6.
12. Deuticke B, Henseleit U, Haest CW, Heller KB, Dubbelman TM. Enhancement of transbilayer mobility of a membrane lipid probe accompanies formation of membrane leaks during photodynamic treatment of erythrocytes. Biochim Biophys Acta 1989;982:53-61.
13. Pooler JP. The kinetics of colloid osmotic hemolysis. I. Nystatin-induced lysis. Biochim Biophys Acta 1985;812: 193-8.
14. Pooler JP. The kinetics of colloid osmotic hemolysis. II. Photohemolysis. Biochim Biophys Acta 1985;812:199-205.
15. Koopman G, Reutelingsperger CP, Kuijten GA, et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84: 1415-20.
16. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184:39-51.
17. Aubry JP, Blaecke A, Lecoanet-Henchoz S, et al. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry 1999;37:197-204.
18. Balasubramanian K, Bevers EM, Willems GM, Schroit AJ. Binding of annexin V to membrane products of lipid peroxidation. Biochemistry 2001;40:8672-6.
19. Hilarius PM, Ebbing IG, Lagerberg JWM, de Korte D, Verhoeven AJ. Loss of phospholipid asymmetry is an early marker of red cell damage after photodynamic treatment (abstract 356). Vox Sang 2002;83(Suppl 2):119.
20. Verhoeven AJ, Hilarlus PM, Ebbing IG, et al. Activation of scramblase as a result of photodynamic treatment of red blood cells (abstract SP154). Transfusion 2003;43S: 88A.
21. Högman CF, Eriksson L, Gong J, et al. Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use. Vox Sang 1993;65:271-8.
22. Wagner S, Skripchenko A, Thompson-Montgomery D. Use of a flow-cell system to investigate virucidal dimethylmethylene blue phototreatment in two RBC additive solutions. Transfusion 2002;42:1200-5.
23. Wagner SJ, Skripchenko A, Robinette D, Foley JW, Cincotta L. Factors affecting virus photoinactivation by a series of phenothiazine dyes. Photochem Photobiol 1998; 67:343-9.
24. Standefer JC, Vanderjagt D. Use of tetramethylbenzidine in plasma hemoglobin assay. Clin Chem 1977;23:749-51.
25. Hess JR, Greenwalt TG. Storage of red blood cells: new approaches. Transfus Med Rev 2002;16:283-95.
26. de Jong K, Geldwerth D, Kuypers FA. Oxidative damage does not alter membrane phospholipid asymmetry in human erythrocytes. Biochemistry 1997;36:6768-76.
27. Besselink GA, Ebbing IG, Hilarius PM, de Korte D, Verhoeven AJ, Lagerberg JW. Composition of the additive solution affects red blood cell integrity after photodynamic treatment. Vox Sang 2003;85:183-9.